Hamilton Capital, LLC Abb Vie Inc. Transaction History

Hamilton Capital, LLC

$1.37 Billion
Q3 2024

A detailed history of Hamilton Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hamilton Capital, LLC holds 13,290 shares of ABBV stock, worth $2.33 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

13,290

Previous 13,037 1.94%

Holding current value

$2.33 Million

Previous $2.24 Million 17.35%

% of portfolio

0.19%

Previous 0.17%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$163.84 - $199.33 $41,451 - $50,430	253 Added 1.94%	13,290 $2.62 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $69,191 - $80,799	-447 Reduced 3.32%	13,037 $2.24 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $92,216 - $105,071	577 Added 4.47%	13,484 $2.46 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $790,924 - $890,767	5,748 Added 80.29%	12,907 $2 Million
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $17,767 - $20,568	-133 Reduced 1.82%	7,159 $1.07 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $85,468 - $106,360	645 Added 9.7%	7,292 $982,000
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $200,574 - $230,990	-1,387 Reduced 17.26%	6,647 $1.06 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $176,206 - $211,318	1,274 Added 18.85%	8,034 $1.3 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $18,520 - $21,242	138 Added 2.08%	6,760 $907,000
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $16,101 - $20,470	117 Added 1.8%	6,622 $1.01 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $58,467 - $72,541	443 Added 7.31%	6,505 $1.06 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $28,361 - $35,885	264 Added 4.55%	6,062 $821,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $9,576 - $10,870	-90 Reduced 1.53%	5,798 $625,000
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $11,047 - $12,307	-105 Reduced 1.75%	5,888 $663,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $1,841 - $2,027	-18 Reduced 0.3%	5,993 $649,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $23,181 - $31,296	288 Added 5.03%	6,011 $644,000
Q3 2020 Nov 19, 2020	SELL	$85.91 - $100.83 $42,525 - $49,910	-495 Reduced 7.96%	5,723 $501,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $42,041 - $56,257	573 Added 10.15%	6,218 $610,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1,290 - $1,955	20 Added 0.36%	5,645 $430,000
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $19.4 Million - $23.3 Million	-308,175 Reduced 98.21%	5,625 $426,000
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $20.2 Million - $25.8 Million	306,802 Added 4384.14%	313,800 $22.8 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $7,714 - $9,079	100 Added 1.45%	6,998 $564,000
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $38,535 - $47,524	-495 Reduced 6.7%	6,898 $551,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $67,215 - $74,723	756 Added 11.39%	7,393 $699,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $594,409 - $651,819	6,637	6,637 $642,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Capital, LLC with notifications on news.

Account

Hamilton Capital, LLC Abb Vie Inc. Transaction History